Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma

American Journal of Surgical Pathology

Volumn 22, Issue 10, 1998, Pages 1215-1221

  Ordóñez, Nelson G ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cytokeratin; Immunohistochemistry; Lung adenocarcinoma; Mesothelioma; Pleura

Indexed keywords

CYTOKERATIN;

ADENOCARCINOMA; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG METASTASIS; PLEURA MESOTHELIOMA; SQUAMOUS CELL CARCINOMA; TRANSITIONAL CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; DIAGNOSIS, DIFFERENTIAL; EPITHELIAL CELLS; EVALUATION STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PLEURAL NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0345647093     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199810000-00006     Document Type: Article

References (48)

1. Amin KM, Litzky LA, Smythe WR, et al. Wilm's tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am J Pathol 1995;146:344-56.
2. Ascoli V, Scalzo CC, Taccogna S, Nardi F. The diagnostic value of thrombomodulin immunolocalization in serous effusions. Arch Pathol Lab Med 1995;119:1136-40.
3. Attanoos RL, Goddard H, Gibbs AR. Mesothelioma-binding antibodies: thrombomodulin, OV 632 and HBME-1 and their use in the diagnosis of malignant mesothelioma. Histopathology 1996; 29:209-15.
4. Attanoos RL, Webb R, Gibbs AR. CD44H expression in reactive mesothelium, pleural mesothelioma and pulmonary adenocarcinoma. Histopathology 1997;30:260-3.
5. Bateman AC, Al-Talib RK, Newman T, Williams JH, Herbert A. Immunohistochemical phenotype of malignant mesothelioma: predictive value of CA125 and HBME-1 expression. Histopathology 1997;30:49-56.
6. Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985;121:235-47.
7. Blobel GA, Moll R, Franke WW, Vogt-Moykopf I. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Arch B Cell Pathol 1984;45:407-29.
8. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993;24:347-54.
9. Chang K, Pai LH, Batra JK, Pastan I, Willingham MC. Characterization of the antigen (CAK1) recognized by monoclonal antibody K1 present on ovarian cancers and normal mesothelium. Cancer Res 1992;52:181-6.
10. Chang K, Pai LH, Pass H, et al. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma. Am J Surg Pathol 1992;16:259-68.
11. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma. Histopathology 1997;31: 140-3.
12. Collins CL, Ordóñez NG, Schaefer R, et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol 1992;141:827-33.
13. Cooper D, Schermer A, Sun TT. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest 1985;52:243-56.
14. Doglioni C, Dei Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, Viale G. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.
15. Donna A, Betta P-G, Chiodera P, Bellingeri D, Libener R, Zorzi F, Tassi GF. Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies. Hum Pathol 1997;28: 929-37.
16. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989;264:4743-6.
17. Franke WW, Schiller M, Hatzfeld M, et al. Protein complexes of intermediate-sized filaments: melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics. Proc Natl Acad Sci USA 1988;80:1713.
18. Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol 1997;28:641-5.
19. Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
20. Jackson DE, Mitchell CA, Bird P, Salem HH, Hayman JA. Immunohistochemical localization of thrombomodulin in normal human skin and skin tumours. J Pathol 1995;175:421-32.
21. Leong AS-Y, Vernon-Roberts E. The immunohistochemistry of malignant mesothelioma. Pathol Annu 1994;29(part 2):157-79.
22. Maruyama I, Bell C, Majerus P. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblasts of human placenta. J Cell Biol 1985;101: 363-71.
23. Miettinen M, Kovatich AJ. HBME-1 - a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft tissue and bone tumors. Appl Immunohistochem 1995;3: 115-22.
24. Miller K, Auld J, Jessup E, Rhodes A, Ashton-Key M. Antigen unmasking in formalin-fixed routinely processed paraffin wax-embedded sections by pressure cooking: a comparison with microwave oven heating and traditional methods. Adv Anatomic Pathol 1995;2:60-4.
25. Moll R, Dhouailly D, Sun TT. Expression of keratin 5 as a distinctive feature of epithelial and biphasic mesotheliomas: an immunohistochemical study using monoclonal antibody AE14. Virchows Arch B Cell Pathol 1989;58:129-45.
26. Moll R, Franke WW. Cytochemical cell typing of metastatic tumors according to their cytoskeletal proteins. In: Lapis K, Liotta LA, Rabson AS, eds. Biochemistry and Molecular Genetics of Cancer Metastasis. Boston: Martinus Nijhoff; 1986:101.
27. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
28. Nagle R. Intermediate filaments: a review of the basic biology. Am J Surg Pathol 1988;12(suppl 1):4-16.
29. O'Hara CJ, Corson JM, Pinkus GS, Stahel RA. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies. Am J Pathol 1990;136:421-8.
30. Ordóñez NG. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989;13:276-91.
31. Ordóñez NG. Value of antibodies 44-3A6, SM3, HBME-1 and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. A comparative study with other commonly used antibodies. Am J Surg Pathol 1997;21:1399-408.
32. Ordóñez NG. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. Am J Clin Pathol 1998;109:85-9.
33. Ordóñez NG. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma. Hum Pathol 1998;29:166-9.
34. Ordóñez NG. Value of thrombomodulin immunostaining in the diagnosis of mesothelioma. Histopathology 1997;31:25-30.
35. Ordóñez NG. Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology 1997;31:517-24.
36. Ordóñez NG, Mackay B. The roles of immunohistochemistry and electron microscopy in distinguishing epithelial mesothelioma of the pleura from adenocarcinoma. Adv Anatomic Pathol 1996;3: 273-93.
37. Peralta-Soler A, Knudsen KA, Jaurand MC, et al. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesothelioma from lung adenocarcinomas. Hum Pathol 1995;26: 1363-9.
38. Renshaw AA, Pinkus GS, Corson JM. HBME-1 aids in distinguishing mesotheliomas and adenocarcinomas of the lung and breast. Mod Pathol 1995;8:152A. Abstract.
39. Riera JR, Astengo-Osuna C, Longmate JA, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma. A reevaluation following heat-induced epitope retrieval. Am J Surg Pathol 1997;21:1409-19.
40. Savera AT, Raju U, Linden MD. Mesothelioma vs. adenocarcinoma: diagnostic utility of HBME-1. Lab Invest 1996;74:162A. Abstract.
41. Singh G, Singh J, Ordóñez NG, et al. Expression of a 130-kDa mesothelial and ciliated cell Ag (MCp130) in normal and developing human and rat lung and its role as a diagnostic marker for mesotheliomas and tumors of the female reproductive system. Lab Invest 1995;73:48-58.
42. Stahel RA, O'Hara CJ, Waibel R, Martin A. Monoclonal antibodies against mesothelial membrane antigen discriminate between mesothelioma and lung adenocarcinoma. Int J Cancer 1988;41: 218-23.
43. Steinert PM, Roop DR. Molecular and cellular biology of intermediate filaments. Ann Rev Biochem 1988;57:593-625.
44. Sun TT, Eichner R, Schermer A, Cooper D, Nelson WG, Weiss RA. Classification, expression and possible mechanisms of evolution of mammalian epithelial keratins: a unifying model. In: Levine A, Topp W, Vande Woude G, Watson JD: eds. The Transformed Phenotype, Cancer Cell, Vol. 1. New York: Cold Spring Harbor Laboratory; 1984:169-76.
45. Wilson JD, Merino MJ, Harris C, Kleiner DE. Mesothelioma vs. adenocarcinoma: does immunohistochemistry help? Lab Invest 1997;76:174A.
46. World Health Organization. The World Health Organization histological typing of lung tumors. Am J Clin Pathol 1982;77:123-36.
47. Yonezawa S, Maruyama I, Sakae K, Igata A, Majerus PW, Sato E. Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin. Am J Clin Pathol 1987;88:405-11.
48. Yonezawa S, Maruyama I, Tanaka S, Nakamura T, Sato E. Immunohistochemical localization of thrombomodulin in chorionic diseases of the uterus and choriocarcinoma of the stomach. A comparative study with the distribution of human chorionic gonadotropin. Cancer 1988;62:569-76.